9069 Results

Journal Article

Evaluation of organ motion-based robust optimisation for VMAT planning for breast and internal mammary chain radiotherapy

Authors: Alex Dunlop, Ruth Colgan, Anna Kirby, Alison Ranger, Irena Blasiak-Wal

Congress Abstract

Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Authors:

Mary Ann Clark1, Ben Slotman2, Enis Ozyar3, Myungsoo Kim4, Jun Itami5, Agnes Tallet6, Juergen Debus7, Raphael Pfeffer8, Piercarlo Gentile9, Yukihiro Hama10, Nicolaus Andratschke11, David Azria12, Philip Camilleri13, Claus Belka14, Magali Quivrin15, Bokyong Kim16, Anders Pedersen17, Mette van Overeem Felter18, Kim Young19, Jin Ho Kim20, Vincenzo Valentini21

1ViewRay Technologies, Inc., Health Economics, Mountain View, USA; 2Amsterdam University medical centers, Radiation Oncology, Amsterdam, The Netherlands; 3Acibadem, Radiation Oncology, Acibadem, Turkey; 4The Catholic University of Korea Incheon Saint Mary's Hospital, Radiation Oncology, Incheon, Korea Republic of; 5National Cancer Center Japan, Radiation Oncology, Tokyo, Japan; 6Institute Paoli Calmettes, Radiation Oncology, Marseille, France; 7Heidelberg University Hospital, Radiation Oncology, Heidelberg, Germany; 8Assuta Medical Centers , Radiation Oncology, Tel Aviv, Israel; 9Opsedale San Pietro Fatebenefratelli di Roma, Radiation Oncology, Rome, Italy; 10Edogawa Hospital, Radiation Oncology, Tokyo, Japan; 11University Hospital Zurich, Radiation Oncology, Zurich, Switzerland; 12Institut Regional du Cancer Montpellier, Radiation Oncology, Montpellier, France; 13GenesisCare-Oxford, Radiation Oncology, Oxford, United Kingdom; 14Klinkum der Universitat Munchen, Radiation Oncology, Munich, Germany; 15Centre Georges-Francois Leclerc, Radiation Oncology, Dijon, France; 16Sheikh Khalifa Specialty Hospital, Radiation Oncology, Ras Al Khaimah, United Arab Emirates; 17Rigshospitalet, Radiation Oncology, Copenhagen, Denmark; 18Herlev Hospital, Radiation Oncology, Herlev, Denmark; 19Chungnam National University Sejong Hospital, Radiation Oncology, Daejeon, Korea Republic of; 20Seoul National University Hospital, Department of Radiation Oncology, Seoul, Korea Republic of; 21Università Cattolica S.Cuore, Fondazione Policlinico Universitario A.Gemelli IRCCS, Radiation Oncology and Hematology, Rome, Italy

Show Affiliations

Congress Abstract

Impact of radiotherapy in immunological parameters in brain metastases by SRS

Authors: Gonzalez-Pose|, Alicia(1);Garcia-Perez|, Ana(1);Gonzalez-Rodriguez|, Monica(2);Lopez Medina|, Antonio(1)*[antonio.lopez.medina@sergas.es];Mirete Bachiller|, Serafin(3);Ochagavia|, Virginia(2);Nieto|, Iñigo(2);Salvador|, Francisco Javier(1);Muñoz Garzón|, Víctor Manuel(2);
(1)Hospital do Meixoeiro, Medical Physics, Vigo Pontevedra, Spain;(2)Hospital do Meixoeiro, Radiation Oncology, Vigo, Spain;(3)Hospital do Meixoeiro, Inmulogía, Vigo, Spain;
Show Affiliations

Congress Abstract

Influence of inter-observer delineation variability on radiomics features of the parotid gland

Authors: Forde|, Elizabeth(1)*[eforde@tcd.ie];Leech|, Michelle(1);Robert|, Charlotte(2);Herron|, Elizabeth(3);Marignol|, Laure(1);
(1)Trinity College Dublin, Discipline of Radiation Therapy, Dublin, Ireland;(2)Gustave Roussy- Universite Paris-Saclay, Department of Medical Physics, Villejuif, France;(3)Trinity College Dublin, Department of Psychiatry, Dublin, Ireland;
Show Affiliations

Congress Abstract

Early outcomes of stereotactic MR-guided adaptive radiation therapy in 54 high-risk lung tumors

Authors: Finazzi|, Tobias(1)*[t.finazzi@vumc.nl];Haasbeek|, Cornelis(1);Palacios|, Miguel(1);Spoelstra|, Femke(1);Admiraal|, Marjan(1);Bruynzeel|, Anna(1);Slotman|, Berend(1);Lagerwaard|, Frank(1);Senan|, Suresh(1);
(1)Amsterdam University Medical Centers VUmc location, Department of Radiation Oncology, Amsterdam, The Netherlands;
Show Affiliations

Congress Abstract

Multicenter study of stereotactic body radiotherapy in non-small cell lung cancer (KROG 17-09)

Authors: Park|, Seung-gyu(1)*[seungkyu0813@hanmail.net];Kim|, Jin Hee(1);Ahn|, Yong Chan (2);Noh|, Jae Myung (2);Kim|, Woo Chul (3);Kang|, Min Kyu (4);Cho|, Jae Ho (5);Kim|, Jae Sung (6);Kong|, Moonkyoo(7);Yea|, Ji Woon(8);Kim|, Yeon Sil (9);Choi|, Kyu Hye (9);Yeo|, Seung Gu (10);
(1)Keimyung University Dongsan Medical Center, Radiation oncology, Daegu, Korea Republic of;(2)Samsung Medical Center, Radiation Oncology, Seoul, Korea Republic of;(3)Inha University Hospital, Radiation Oncology, Incheon, Korea Republic of;(4)School of Medicine- Kyungpook National University, Radiation Oncology, Daegu, Korea Republic of;(5)Yonsei University College of Medicine, Radiation Oncology, Seoul, Korea Republic of;(6)Seoul National University Bundang Hospital, Radiation Oncology, Seongnam, Korea Republic of;(7)Kyung Hee University Medical Center, Radiation Oncology, Seoul, Korea Republic of;(8)Yeungnam University College of Medicine, Radiation Oncology, Daegu, Korea Republic of;(9)College of Medicine- The Catholic University, Radiation Oncology, Seoul, Korea Republic of;(10)Soonchunhyang University College of Medicine, Radiation Oncology, Cheonan, Korea Republic of;
Show Affiliations

Congress Abstract

Long-Term Quality of Life after (chemo)radiotherapy for high-risk Endometrial Cancer in PORTEC-3

Authors: POST|, Cathalijne(1)*[C.C.B.Post@lumc.nl];de Boer|, Stephanie M(1);Powell|, Melanie E(2);Mileshkin|, Linda(3);Katsaros|, Dionyssios(4);Bessette|, Paul(5);Haie-Meder|, Christine(6);Ottevanger|, Petronella B(7);Ledermann|, Jonathan A(8);Khaw|, Pearly(9);D'Amico|, Romerai(10);Fyles|, Anthony(11);Baron|, Marie-Helene(12);Kitchener|, Henry C(13);Nijman|, Hans W(14);Lutgens|, Ludy CHW(15);Brooks|, Susan(16);Jürgenliemk-Schulz|, Ina M(17);Feeney|, Amanda(8);Nout|, Remi A(1);Verhoeven-Adema|, Karen W(18);Smit|, Vincent THBM(19);Putter|, Hein(20);Creutzberg|, Carien L(1);
(1)Leiden University Medical Center, Radiation Oncology, Leiden, The Netherlands;(2)Barts Health NHS Trust, Clinical Oncology, London, United Kingdom;(3)Peter MacCallum Cancer Centre, Cancer Medicine, Melbourne, Australia;(4)Città della Salute and S Anna Hospital, Surgical Sciences, Torino, Italy;(5)University of Sherbrooke, Obstetrics and Gynaecology, Sherbrooke, Canada;(6)Institus Gustave Roussy, Radiotherapy, Villejuif, France;(7)Radboudumc, Medical Oncology, Nijmegen, The Netherlands;(8)UCL Cancer Institute, Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom;(9)Peter MacCallum Cancer Center, Radiation Oncology, Melbourne, Australia;(10)Azienda Ospedaliera della Provincia di Lecco, Radiotherapy, Lecco, Italy;(11)Princess Margaret Cancer Centre, Radiation Oncology, Toronto, Canada;(12)Centre Hospitalier Régional Universitaire de Besançon, Radiotherapy, Besançon, France;(13)University of Manchester, Institute of Cancer Sciences, Manchester, United Kingdom;(14)University Medical Center Groningen, Gynaecologic Oncology, Groningen, The Netherlands;(15)MAASTRO, Radiation Oncology, Maastricht, The Netherlands;(16)Auckland City Hospital, Radiation Oncology, Auckland, New Zealand;(17)University Medical Center Utrecht, Radiation Oncology, Utrecht, The Netherlands;(18)Comprehensive Cancer Center Netherlands, Central Data Management and Trial Coordination, Leiden, The Netherlands;(19)Leiden University Medical Center, Pathology, Leiden, The Netherlands;(20)Leiden University Medical Center, Medical Statistics, Leiden, The Netherlands;
Show Affiliations

Congress Abstract

Hypofractionated image guided re-irradiation in head - neck cancers; an Indian experience

Authors: Talapatra|, Kaustav(1)*[kaustee@gmail.com];Chadha|, Pranav (2); Deshpande|, Mandar(3);Mistry |, Rajesh(3);Vadgaonkar|, Rohit(2);Mhatre|, Vaibhav(2);Pilakkal|, Shaju(4);Goyle|, Sandeep(5);Limaye|, Sewanti(5);Shaikh|, Imran(6);Badhwar|, Sanjiv(7);
(1)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Radiation Oncology -, Mumbai, India;(2)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Radiation Oncology, Mumbai, India;(3)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Surgical Oncology, Mumbai, India;(4)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute-, Radiation Oncology, Mumbai, India;(5)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Medical Oncology, Mumbai, India;(6)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Medical Onocology, Mumbai, India;(7)Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Otorhinolaryngology, Mumbai, India;
Show Affiliations

Congress Abstract

C-reactive protein-to-albumin ratio is a predictive marker for anal squamous cell carcinoma

Authors: Martin|, Daniel(1)*[daniel.martin@kgu.de];Rödel|, Franz(1);Balermpas|, Panagiotis(2);Winkelmann|, Ria(3);Rödel|, Claus(1);Fokas|, Emmanouil(1);
(1)University of Frankfurt, Department of Radiotherapy and Oncology, Frankfurt, Germany;(2)University Hospital Zürich, Department of Radiation Oncology, Zürich, Switzerland;(3)University of Frankfurt, Senckenberg Institute for Pathology, Frankfurt, Germany;
Show Affiliations
*:*